157 related articles for article (PubMed ID: 36625084)
1. Diagnosis and management of hepatic encephalopathy: The French recommendations.
Thabut D; Bouzbib C; Meunier L; Haas M; Weiss N; Louvet A; Imbert-Bismut F; Mochel F; Nadjar Y; Santiago A; Thevenot T; Duhalde V; Oberti F; Francoz C; Coilly A; Hilleret MN; Lebray P; Liou-Schischmanoff A; Barbier L; Duvoux C; Pageaux GP; Bismuth M; Galanaud D; Broucker T; Cadranel JF; Leroy V; Di Martino V; Larrey D; Camus C; Scatton O; De Ledinghen V; Mallat A; Rudler M; Bureau C;
Liver Int; 2023 Apr; 43(4):750-762. PubMed ID: 36625084
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.
Nardelli S; Gioia S; Pasquale C; Pentassuglio I; Farcomeni A; Merli M; Salvatori FM; Nikolli L; Torrisi S; Greco F; Nicoletti V; Riggio O
Am J Gastroenterol; 2016 Apr; 111(4):523-8. PubMed ID: 26925879
[TBL] [Abstract][Full Text] [Related]
3. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
4. Interventional Radiology Management of Hepatic Encephalopathy.
Lee EW; Liang JJ; McNamara GP
Clin Liver Dis; 2024 May; 28(2):317-329. PubMed ID: 38548442
[TBL] [Abstract][Full Text] [Related]
5. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
[TBL] [Abstract][Full Text] [Related]
6. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
8. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
10. Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Li J; Wang D; Sun J
Medicine (Baltimore); 2022 Jan; 101(3):e28584. PubMed ID: 35060521
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management.
Li X; Partovi S; Coronado WM; Gadani S; Martin C; Thompson D; Levitin A; Kapoor B
Cardiovasc Intervent Radiol; 2022 May; 45(5):570-577. PubMed ID: 34981195
[TBL] [Abstract][Full Text] [Related]
12. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
13. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
Riggio O; Angeloni S; Salvatori FM; De Santis A; Cerini F; Farcomeni A; Attili AF; Merli M
Am J Gastroenterol; 2008 Nov; 103(11):2738-46. PubMed ID: 18775022
[TBL] [Abstract][Full Text] [Related]
14. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
16. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
17. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
Deng D; Liao MS; Qin JP; Li XA
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
[TBL] [Abstract][Full Text] [Related]
18. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.
Zhang LJ; Qi R; Zhong J; Xu Q; Zheng G; Lu GM
PLoS One; 2012; 7(8):e42824. PubMed ID: 22912746
[TBL] [Abstract][Full Text] [Related]
19. The assessment and management of cirrhotic patients with encephalopathy.
Kibble H; Shawcross DL
United European Gastroenterol J; 2024 Mar; 12(2):187-193. PubMed ID: 38180440
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
